US Pharma MarketingCDMO Samsung Biologics estimates $102M impact stemming from ongoing union strike
The company chalks up a financial impact of about 150 billion Korean won ($102 million) from "preemptive production adjustments" made to mitigate potential manufacturing impacts, a spokesperson said.
The company chalks up a financial impact of about 150 billion Korean won ($102 million) from "preemptive production adjustments" made to mitigate potential manufacturing impacts, a spokesperson said.
Source: FiercePharma